What is Chaitanya Mamillapalli's NPI number?

Chaitanya Mamillapalli's National Provider Identifier (NPI) is 1710137930, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Chaitanya Mamillapalli's specialty?

Chaitanya Mamillapalli is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).

Where is Chaitanya Mamillapalli located?

Chaitanya Mamillapalli's practice location on file with NPPES is 350 W Carpenter St, Springfield, IL 62702-4902.

What is Chaitanya Mamillapalli's phone number?

The practice phone number listed in the NPPES registry for Chaitanya Mamillapalli is (217) 528-7541.

Does Chaitanya Mamillapalli accept Medicare?

Chaitanya Mamillapalli is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Chaitanya Mamillapalli's NPI active?

Yes — Chaitanya Mamillapalli's NPI (1710137930) is active in the NPPES registry as of the last update on 2020-05-21.

IndividualActiveAccepts Medicare

Chaitanya Mamillapalli, M.D, MRCP

NPI 1710137930 · Endocrinology, Diabetes & Metabolism Physician · Springfield, IL

Chaitanya Mamillapalli, M.D, MRCP is a Endocrinology, Diabetes & Metabolism Physician provider in Springfield, IL (NPI 1710137930).

Provider details

NPI number: 1710137930
Entity type: Individual
Primary specialty: Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
Credential: M.D, MRCP
Sex: Male
Sole proprietor: No
License: 036-125425 (IL)

Practice location

350 W Carpenter St

Springfield, IL 62702-4902

Phone: (217) 528-7541

Street-level locationGet directions

More IL providers

Mailing address

Po Box 19248

Springfield, IL 62794-9248

Specialties & taxonomies

Endocrinology, Diabetes & Metabolism PhysicianPrimary207RE0101XLicense 036-125425 (IL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(80/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
18 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,443 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	416	$124
Insertion of Needle Into Vein for Collection of Blood Sample36415	360	$8
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	327	$16
Injection of Drug Or Substance Under Skin Or Into Muscle96372	107	$14
Continuous Monitoring of Blood Sugar Level in Tissue Fluid Using Sensor Under Skin With Interpretation and Report95251	70	$34
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 60 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Levothyroxine Sodium	585	136
Semaglutidebrand: Ozempic	417	82
Insulin Glargine,hum.rec.anlogbrand: Lantus Solostar	224	70
Alendronate Sodium	168	53
Metformin Hcl	161	46
Insulin Aspartbrand: Novolog Flexpen	156	54
Empagliflozin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$431 across 22 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2008-09-24
Last updated: 2020-05-21
Certified: 2020-05-21

Frequently asked questions

What is Chaitanya Mamillapalli's NPI number?: Chaitanya Mamillapalli's National Provider Identifier (NPI) is 1710137930, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Chaitanya Mamillapalli's specialty?: Chaitanya Mamillapalli is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
Where is Chaitanya Mamillapalli located?: Chaitanya Mamillapalli's practice location on file with NPPES is 350 W Carpenter St, Springfield, IL 62702-4902.
What is Chaitanya Mamillapalli's phone number?: The practice phone number listed in the NPPES registry for Chaitanya Mamillapalli is (217) 528-7541.
Does Chaitanya Mamillapalli accept Medicare?: Chaitanya Mamillapalli is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Chaitanya Mamillapalli's NPI active?: Yes — Chaitanya Mamillapalli's NPI (1710137930) is active in the NPPES registry as of the last update on 2020-05-21.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	416	$124
Insertion of Needle Into Vein for Collection of Blood Sample36415	360	$8
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	327	$16
Injection of Drug Or Substance Under Skin Or Into Muscle96372	107	$14
Continuous Monitoring of Blood Sugar Level in Tissue Fluid Using Sensor Under Skin With Interpretation and Report95251	70	$34
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 60 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Levothyroxine Sodium	585	136
Semaglutidebrand: Ozempic	417	82
Insulin Glargine,hum.rec.anlogbrand: Lantus Solostar	224	70
Alendronate Sodium	168	53
Metformin Hcl	161	46
Insulin Aspartbrand: Novolog Flexpen	156	54
Empagliflozin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$431 across 22 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments